Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dna X (SONM) Cash from Investing Activities (2018 - 2024)

Historic Cash from Investing Activities for Dna X (SONM) over the last 7 years, with Q4 2024 value amounting to -$8000.0.

  • Dna X's Cash from Investing Activities rose 3333.33% to -$8000.0 in Q4 2024 from the same period last year, while for Dec 2024 it was -$214000.0, marking a year-over-year decrease of 132666.67%. This contributed to the annual value of -$214000.0 for FY2024, which is 49444.44% down from last year.
  • Per Dna X's latest filing, its Cash from Investing Activities stood at -$8000.0 for Q4 2024, which was up 3333.33% from -$137000.0 recorded in Q3 2024.
  • In the past 5 years, Dna X's Cash from Investing Activities ranged from a high of $192000.0 in Q4 2020 and a low of -$184000.0 during Q1 2020
  • Moreover, its 5-year median value for Cash from Investing Activities was -$9500.0 (2020), whereas its average is -$19428.6.
  • Per our database at Business Quant, Dna X's Cash from Investing Activities surged by 29009.9% in 2020 and then plummeted by 1360000.0% in 2024.
  • Quarter analysis of 5 years shows Dna X's Cash from Investing Activities stood at $192000.0 in 2020, then crashed by 113.54% to -$26000.0 in 2021, then skyrocketed by 92.31% to -$2000.0 in 2022, then plummeted by 500.0% to -$12000.0 in 2023, then soared by 33.33% to -$8000.0 in 2024.
  • Its last three reported values are -$8000.0 in Q4 2024, -$137000.0 for Q3 2024, and -$39000.0 during Q2 2024.